Lyra Therapeutics, Inc. — Form D

Lyra Therapeutics, Inc. of Watertown, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-26. The offering totals $100.5M, of which $100.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (40)

Showing 25 of 40 people.

NameRoleLocation
Pamela NelsonExecutive OfficerWatertown, MA
Corinne NoyesExecutive OfficerWatertown, MA
Robert Richard, Ph.D.Executive OfficerWatertown, MA
Robert LangerDirectorPittsburgh, PA
Guido NeelsDirectorTORONTO, A6
Bradford SmithDirectorOttawa, Ontario, Z4
Carmichael RobertsDirectorMALDEN, MA
Maria PalasisDirectorAustin, TX
Maria PalasisExecutive OfficerAustin, TX
Konstantin PoukalovDirectorMarlton, NJ
James GoldsteinDirectorBoston, MA
James R TobinDirectorMarlton, NJ
W. Bradford SmithDirectorWatertown, MA
Konstantin Ann PoukalovDirectorWatertown, MA
Maria Palasis, Ph.D.DirectorWatertown, MA
Maria Palasis, Ph.D.Executive OfficerWatertown, MA
Nancy Bradford Snyderman, M.D., FACSDirectorWatertown, MA
C. Ann MerrifieldDirectorWatertown, MA
Richard R Nieman, M.D.Executive OfficerWatertown, MA
Harlan Waksal, M.D.DirectorWatertown, MA
Harlan Waksal, M.D.Executive OfficerWatertown, MA
John R Bishop, Ph.D.Executive OfficerWatertown, MA
Jason CavalierExecutive OfficerWatertown, MA
Michael AltmanDirectorWatertown, MA
Edward AndersonDirectorWatertown, MA

Other filings by this issuer (12)

FiledFormOfferingSold
2023-06-09D$50.0M$50.0M
2020-01-27D$28.0M$28.0M
2016-11-28D$6.0M$6.0M
2013-04-12D$21.2M$18.0M
2012-10-30D$6.0M$5.1M
2011-11-08D$3.0M$3.0M
2011-09-08D$18.0M$12.0M
2010-08-12D$3.0M$3.0M
2010-05-18D$10.1M$10.1M
2010-03-19D$1.0M$1.0M
2010-01-20D$2.0M$2.0M
2009-04-14D$12.2M$8.2M

More